reports
Celyad Oncology Présentera au Congrès Annuel SITC 2024
MONT-SAINT-GUIBERT, Belgique--(BUSINESS WIRE)-- Regulatory News: Celyad Oncology (Euronext: CYAD) (la “Société”), annonce aujourd'hui la présentation de deux posters lors de la 39e réunion annuelle de la Society for Immunotherapy of Cancer (SITC), qui se tiendra à Houston du 6 au 10 novembre 2024. Détail des Présentations de Posters Abstract 262: PSMA/NKG2DL tandem CAR T-cells to overcome antigen heterogeneity and improve anti-tumor efficacy against prostate cancer. Présentation le samedi 9 novembre à la session de posters (Cellular Therapies) Abstract 1133: Efficient, safe and customiza...
- Carole Braudeau
- Carole Braudeau
- Jacob Mekhael
- Thomas Vranken
- Wim Hoste
- Wim Hoste
Ontex FIRST LOOK: Divestment of Brazil is a big step in strategy execu...
The binding agreement announced today to sell the Brazilian business to Softys allows Ontex to further progress on its strategic agenda to focus on its European and North American businesses, leaving only one remaining non-core asset (Turkey) for the time being. Despite our enthusiasm on the strategic progress, the deal value (€ 110m or 5-5.5x EV/EBITDA24e) is not overwhelmingly positive, certainly when taking into account the significant leakage on transaction and tax expenses. We continue to a...
Ontex reaches important milestone in reshaping its portfolio with bin...
Ontex reaches important milestone in reshaping its portfolio with binding agreement to sell its Brazilian business to Softys Aalst, Belgium, September 30, 2024 – Ontex Group NV (Euronext: Ontex), a leading international developer and producer of personal care products, announces that it has entered into a binding agreement to sell its Brazilian business activities to Softys S.A. for an enterprise value of BRL 671 million (or approximately €110 million*). Softys is a personal hygiene company with operations across Latin America, that also acquired Ontex’s Mexican business activities in 2023...
Celyad Oncology annonce la nomination de Matt Kane au poste de CEO
MONT-SAINT-GUIBERT, Belgique--(BUSINESS WIRE)-- Regulatory News: Celyad Oncology SA (Euronext & Nasdaq : CYAD) (la « Société » ou « Celyad ») est heureuse d’annoncer la nomination de Matt Kane au poste de Directeur Général (Chief Executive Officer ou CEO en anglais), à compter du 1er octobre 2024. Matt Kane est un dirigeant chevronné avec plus de 20 ans d’expérience en entrepreneuriat, CEO et membre de conseil d’administration. M. Kane a été un des pionniers de l’édition de génome et a dirigé le développement de la première technologie d’édition à recevoir l’autorisation d’évaluation cliniqu...
Celyad Oncology publie ses résultats financiers pour le premier semest...
MONT-SAINT-GUIBERT, Belgique--(BUSINESS WIRE)-- Regulatory News: Celyad Oncology (Euronext: CYAD) (la “Société”), annonce aujourd'hui ses résultats financiers pour le premier semestre 2024 clos le 30 juin 2024, et fait le point sur ses activités. Michel Lussier, CEO par intérim de Celyad Oncologie, a commenté : “Celyad Oncology continue de faire des progrès remarquables dans le développement de technologies de pointe pour la thérapie à base de lymphocytes T à récepteur antigénique chimérique (CAR-T). Notre plateforme multiplex révolutionne le potentiel des cellules CAR -T, tandis que notre p...
- Sharad Kumar S.P
Holdings Report - August 2024 KBCS Holdings Universe Up 0.5% Thanks To...
1M Performance - Absolute: During July'24 (1M period), the KBCS Holdings Universe posted a return of 0.5% which was mainly driven by multi-asset holdings (+1.7%) while single-asset holdings posted a negative return of -1.3%. The 3 top performers during the period were HAL Trust (+5.1%), Texaf (+2.9%), and The Infrastructure Company (TINC, +9.6%) while the 3 worst performers were Brederode (-2.8%), Solvac (-5.3%), and Whitestone Group (-7.2%). YTD Performance - Relative: On a YTD basis (as of A...
GBLB GROUPE BRUXELLES LAMBERT SA
HAL HAL TRUST
DIE D'IETEREN SA
SOF SOFINA SA
SOLV SOLVAC S.A.
GIMB GIMV NV
QFG QUEST FOR GROWTH
ACKB ACKERMANS & VAN HAAREN NV
TUB FINANCIERE DE TUBIZE S.A.
HEIO HEINEKEN HOLDING N.V.
KBCA KBC ANCORA SCA
TEXF TEXAF
BREB BREDERODE S.A.
TINC TINC COMM. VA
ROCK WHITESTONE GROUP
- ING Helpdesk
Benelux Morning Notes
ING Benelux Conference London: Aalberts, Arcadis, Azelis, Barco, Basic-Fit, Brunel International, DEME Group, Euronext, Fagron, Heijmans, Kinepolis, Lotus Bakeries, Melexis, Ontex, Randstad, Recticel, SBM Offshore, TKH Group, Van Lanschot Kempen Other company stories - OCI: Divestment of Methanol to Methanex for US$2.05bn, Staffing: US August temp volumes marginally better trend; NFP jobs miss
BFIT BASIC-FIT NV
SBMO SBM OFFSHORE NV
FAGR FAGRON SA
RAND RANDSTAD NV
LOTB LOTUS BAKERIES NV
REC RECTICEL SA
HEIJM HEIJMANS N.V. CERT
VLK
ARCAD VAN LANSCHOT KEMPEN NV CERT. OF SHS
AALB ARCADIS NV
OCI AALBERTS N.V.
BRNL OCI NV
ONTEX BRUNEL INTERNATIONAL N.V.
MELE ONTEX GROUP N.V.
TWEKA MELEXIS NV
KIN TKH GROUP N.V. CERT
BAR KINEPOLIS GROUP NV
AZE BARCO NV
DEME AZELIS GROUP NV
DEME GROUP NV
- Jacob Mekhael
- Sharad Kumar S.P
- Wim Hoste
- Wim Lewi
- Reg Watson
- CFA
BANIMMO NV: HALFJAARRESULTATEN 2024
BANIMMO NV: HALFJAARRESULTATEN 2024 HIGHLIGHTS Huurinkomsten bereiken € 3,6 miljoen, een substantiële stijging van 38% ten opzichte van € 2,6 miljoen op 30 juni 2023Bezettingsgraad stijgt met 1,67% verder tot 92,30% t.o.v. 31 december 2023Geconsolideerd nettoresultaat (IFRS) van het halfjaar eindigt op € 2,5 miljoen, ten opzichte van € 160K op 30 juni 2023. Netto-positieve aanpassing van de reële waarde van de vastgoedbeleggingen met € 2,6 miljoen, voornamelijk ingevolge de waardering van het project NETWORKS Gent ATMOS in uitvoeringBoekhoudkundig netto-actief per aandeel van € 6,20 t....
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Michiel Declercq
- Wim Hoste
- Wim Lewi
Ontex brings its Dreamshield® 360º technology in baby pants to market ...
Ontex brings its Dreamshield® 360º technology in baby pants to market across Europe Ontex confirms commercialization of Dreamshield® 360º technologyDreamshield® 360º technology excels in independent consumer panelsContinued strong market growth as consumers shift from diapers to baby pants Aalst, Belgium, August 29, 2024 – Ontex Group NV, a leading international developer and producer of personal care products, is proud to announce the commercial launch of its newest baby pants, featuring its Dreamshield® 360º innovation. The Dreamshield® 360° technology - designed with a unique pee & po...
- Guy Sips
- Hilde Van Boxstael
- Thibault Leneeuw
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Wim Hoste
Tessenderlo Model update – lowering estimates and lowering TP
We have lowered our adjusted EBITDA forecasts for FY24-26 by 8% following the FY24 guidance reduction from a flat result to a 5-10% drop. Whilst business conditions in a number of end markets are clearly challenging, Tessenderlo is still generating sizeable FCF (close to €100m in 1H). Starting from a very solid balance sheet, capital allocation is a crucial theme in the equity story. We view share buybacks as an excellent way to create shareholder value and welcome the awaited simplification of ...
- ING Helpdesk
Benelux Morning Notes
ASR: 1H small beat, KNAB add-on to Solvency 2 higher. Avantium: Down to the wire. Flow Traders: Pump up the volume. Greenyard: 1Q24/25 preview. Kendrion: Navigating difficult end markets. Montea: Solid results with no surprises, guidance reiterated. NEPI Rockcastle: Guidance raised, M&A opportunities on the radar. Tessenderlo: 1H24 Adj. EBITDA miss of 5%, lower FY guidance
- Wim Hoste
Tessenderlo FIRST LOOK: 1H adj. EBITDA -26.5%, FY guidance lowered
1H adj EBITDA dropped by 26.5% and was 1% better than our forecast although 5% below consensus. FY adj EBITDA guidance has been lowered from a flat result to a 5-10% drop whilst we and consensus were banking on +2%. Whilst business conditions in a number of end markets are clearly challenging, Tessenderlo is still generating sizeable FCF (close to €100m in 1H). Starting from a very solid balance sheet, capital allocation is a crucial theme in the equity story. We view share buybacks as an excell...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.